You must learn how to read. From the announcement today
The Future of Magnetic Relaxometry (MRX) The Company plans to continue to develop the proprietary detection technology, known as magnetic relaxometry (MRX) in collaboration with academic and industry partners, focusing on a new generation of small magnetic sensors that could enable the use of magnetic relaxometry in the doctor’s office. In the future MRX could be a game-changing instrument that would allow non-invasive cancer diagnosis at the first point of care, e.g. at the urologist or OB/Gyn or general practitioner.
IBX Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
